文档下载 文档下载导航
设为首页 | 加入收藏
搜索 请输入内容:  
 导航当前位置: 文档下载 > 所有分类 > 医药卫生 > 临床医学 > 541例女性晚期非小细胞肺癌患者的预后因素分析
侵权投诉

541例女性晚期非小细胞肺癌患者的预后因素分析

541例女性晚期非小细胞肺癌患者的预后因素分析

中国肺癌杂志2011年3月第14卷第3期Chin J Lung Cancer, March 2011, Vol.14, No.3

·245·

DOI: 10.3779/j.issn.1009-3419.2011.03.21

·临床研究·

541例女性晚期非小细胞肺癌患者的

预后因素分析

吴梅娜* 王玉艳* 安彤同 赵军 杨鹭 段建春 王志杰 卓明磊 白桦 刘叙仪 王洁

【摘要】 背景与目的 随着女性肺癌发病率的攀升,其独特的临床和流行病学特征及良好预后引起了学界的关注。本研究通过回顾性分析女性晚期非小细胞肺癌(non-small cell lung cancer, NSCLC)患者的临床资料,探讨其预后相关因素。方法 收集541例女性晚期NSCLC患者的临床资料,并随访至死亡。主要观察指标为总生存(overall survival, OS)。采用SPSS 11.0统计软件进行生存分析。结果 全组腺癌占80.2%(434/541),总体中位OS为15个月(95%CI: 13.87-16.13),1年、2年、5年生存率分别为58.8%、23.7%和3.20%。单因素分析显示,临床分期、ECOG评分、体重下降、临床症状、血行转移和一线治疗后化疗方案数>1、一线化疗有效、曾接受靶向治疗或放疗均与中位OS明显相关(P值均<0.05)。治疗前体重下降、ECOG评分、靶向治疗及一线化疗有效为生存的独立预后因素(P值均<0.05)。结论 女性晚期NSCLC患者的病理类型以腺癌为主,体重下降、ECOG评分、接受靶向治疗及一线化疗有效可能成为女性晚期NSCLC患者生存的独立预后指标。

【关键词】 肺肿瘤;女性;生存;预后【中图分类号】 R734.2

Meina WU*, Yuyan WANG*, Tongtong AN, Jun ZHAO, Lu YANG, Jianchun DUAN, Zhijie WANG, Minglei ZHUO, Hua BAI,

Xuyi LIU, Jie WANG

Meina WU and Yuyan WANG are equally contributed to this study.

Department of Thoracic Oncology, Beijing Cancer Hospital, Beijing University Oncology College, Beijing 100142, China Corresponding author: Jie WANG, E-mail: wangjie_cc@yahoo.com

【Abstract】 Background and objective As there is a sharp increase in the incidence of lung cancer in women in re-cent years, it has brought broad concerns with its unique clinical and epidemiological characteristics and better prognosis. The aim of this study is to analyze the clinical data of women with advanced non-small cell lung cancer (NSCLC) retrospectively to explore the prognostic factors. Methods Clinical data of 541 female patients with advanced NSCLC were collected and fol-lowed up till death. The primary endpoint is overall survival (OS). SPSS 11.0 statistical analysis software was used for univariate and multivariate analysis. Results The mean age is 59 years (20 years-86 years), adenocarcinoma account for 80.2% (434/541). The median OS was 15 months (95%CI: 13.87-16.13), and 1, 2, 5-year survival rates were 58.8%, 23.7% and 3.20% respective-ly. Univariate analysis showed that clinical stage, ECOG score, weight loss, clinical symptoms, liver/bone/brain metastasis and received more than one chemotherapy regimen, good response to the first-line chemotherapy, EGFR-TKI targeted therapy and radiotherapy treatment were significantly correlated with the OS and survival rate (P<0.05). Combined with multivariate anal-ysis, weight loss before treatment, ECOG score, received EGFR-TKI targeted therapy and response to first-line chemotherapy were independent prognostic factor for survival (P<0.05). Conclusion There is a higher percentage of adenocarcinoma in fe-male NSCLC. Weight loss before treatment, ECOG score, EGFR-TKI targeted therapy and response to first-line chemotherapy may become independent prognostic factors for survival of female patients with advanced NSCLC.

【Key words】 Lung neoplams; Female; Survival; Prognosis

Analysis of Prognostic Factors in 541 Female Patients

with Advanced Non-small Cell Lung Cancer

20世纪初关于女性肺癌的报道还很少见,但流行病学研究发现1990年-2003年美国女性肺癌新发病例数增加

吴梅娜和王玉艳为共同第一作者。

作者单位:100142 北京,北京大学临床肿瘤学院,北京肿瘤医院胸部肿瘤内科(通讯作者:王洁,E-mail: wangjie_cc@yahoo.com )

了60%,而男性则保持稳定,肺癌已经成为女性恶性肿瘤的第一位死亡原因[1]。我国卫生部全国肿瘤防治研究办公室提供的资料[2]也显示2000年-2005年间中国女性肺癌新患者从12万人增至17万人,增长速度已超过男性。因此提高对女性肺癌的关注已经成为改善肺癌总体生存

第1页

你可能喜欢

热门文档

相关文档

站点地图 | 文档上传 | 侵权投诉 | 手机版
本站所有资源均来自互联网,本站只负责收集和整理,均不承担任何法律责任,如有侵权等其它行为请联系我们.
文档下载 Copyright 2013 doc.guandang.net All Rights Reserved.  -  email